Fornetti J, Welm AL, Stewart SA. Understanding the Bone in Cancer Metastasis. J Bone Miner Res. 2018;33(12):2099–113. https://doi.org/10.1002/jbmr.3618.
Article CAS PubMed Google Scholar
Ferreira AR, Abrunhosa-Branquinho AN, Jorge M, Costa L. Bone Metastasis. In: De Mello RA, Mountzios G, Tavares ÁA, editors. International Manual of Oncology Practice: iMOP - Principles of Oncology. Cham: Springer International Publishing; 2019. p. 1115–37.
Huang JF, Shen J, Li X, Rengan R, Silvestris N, Wang M, et al. Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study. Ann Transl Med. 2020;8(7):482. https://doi.org/10.21037/atm.2020.03.55.
Article PubMed PubMed Central Google Scholar
Jiang W, Rixiati Y, Zhao B, Li Y, Tang C, Liu J. Incidence, prevalence, and outcomes of systemic malignancy with bone metastases. J Orthop Surg (Hong Kong). 2020;28(2):2309499020915989. https://doi.org/10.1177/2309499020915989.
Pockett RD, Castellano D, McEwan P, Oglesby A, Barber BL, Chung K. The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain. Eur J Cancer Care. 2010;19(6):755–60. https://doi.org/10.1111/j.1365-2354.2009.01135.x.
DiCaprio MR, Murtaza H, Palmer B, Evangelist M. Narrative review of the epidemiology, economic burden, and societal impact of metastatic bone disease. Ann Jt. 2022;7:28. https://doi.org/10.21037/aoj-20-97.
Article PubMed PubMed Central Google Scholar
Abdul-Karim FW, Kida M, Wentz WB, Carter JR, Sorensen K, Macfee M, et al. Bone metastasis from gynecologic carcinomas: a clinicopathologic study. Gynecol Oncol. 1990;39(2):108–14. https://doi.org/10.1016/0090-8258(90)90414-g.
Article CAS PubMed Google Scholar
Zhang C, Guo X, Peltzer K, Ma W, Qi L, Zhang Y, et al. The prevalence, associated factors for bone metastases development and prognosis in newly diagnosed ovarian cancer: a large population based real-world study. J Cancer. 2019;10(14):3133–9. https://doi.org/10.7150/jca.30335.
Article PubMed PubMed Central Google Scholar
Ak N, Minareci Y, Saip P. Skeletal system as a rare metastatic site in patients with ovarian carcinoma. Int J Gynecol Cancer. 2021;31(8):1125–31. https://doi.org/10.1136/ijgc-2021-002486.
Gardner AB, Charo LM, Mann AK, Kapp DS, Eskander RN, Chan JK. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes. Clin Exp Metastasis. 2020;37(1):107–13. https://doi.org/10.1007/s10585-019-10007-0.
Zhang Y, Guo X, Wang G, Ma W, Liu R, Han X, et al. Real-world study of the incidence, risk factors, and prognostic factors associated with bone metastases in women with uterine cervical cancer using surveillance, epidemiology, and end results (SEER) data analysis. Med Sci Monit. 2018;24:6387–97. https://doi.org/10.12659/msm.912071.
Article PubMed PubMed Central Google Scholar
Fischer F, Kuhl M, Feek U, Rominger M, Schipper ML, Hadji P, et al. Bone metastases in vulvar cancer: a rare metastatic pattern. Int J Gynecol Cancer. 2005;15(6):1173–6. https://doi.org/10.1111/j.1525-1438.2005.00175.x.
Article CAS PubMed Google Scholar
Prieske K, Haeringer N, Grimm D, Trillsch F, Eulenburg C, Burandt E, et al. Patterns of distant metastases in vulvar cancer. Gynecol Oncol. 2016;142(3):427–34. https://doi.org/10.1016/j.ygyno.2016.07.009.
Ramirez-Espinoza A, Vela I, Server L, Roudriguez-Celdrán JM, Chuliá MT, Quereda F. Placental-site trophoblastic tumor with bone metastasis: A diagnostic and therapeutic challenge. Gynecol Oncol Rep. 2023;50:101304. https://doi.org/10.1016/j.gore.2023.101304.
Article PubMed PubMed Central Google Scholar
Deng K, Yang C, Tan Q, Song W, Lu M, Zhao W, et al. Sites of distant metastases and overall survival in ovarian cancer: a study of 1481 patients. Gynecol Oncol. 2018;150(3):460–5. https://doi.org/10.1016/j.ygyno.2018.06.022.
Ghosh S, Rao PB. Osseous metastases in gynaecological epithelial malignancies: a retrospective institutional study and review of literature. J Clin Diagn Res. 2015;9(12):Xc10-xc3. https://doi.org/10.7860/jcdr/2015/15063.6925.
Article PubMed PubMed Central Google Scholar
Mantyh PW. Bone cancer pain: from mechanism to therapy. Curr Opin Support Palliat Care. 2014;8(2):83–90. https://doi.org/10.1097/spc.0000000000000048.
Article PubMed PubMed Central Google Scholar
Falk S, Dickenson AH. Pain and Nociception: Mechanisms of Cancer-Induced Bone Pain. J Clin Oncol. 2014;32(16):1647–54. https://doi.org/10.1200/jco.2013.51.7219.
Article CAS PubMed Google Scholar
Wallace E, Slaven M, Slaven M, Slaven M, Wennberg R, Wennberg R, et al. Pain in Bone Metastases: Types and Mechanisms. In: Vassiliou V, Chow E, Kardamakis D, editors., et al., Bone Metastases: A translational and Clinical Approach. Dordrecht: Springer, Netherlands; 2014. p. 37–49.
Vassiliou V, Kalogeropoulou C, Petsas T, Leotsinidis M, Kardamakis D. Clinical and radiological evaluation of patients with lytic, mixed and sclerotic bone metastases from solid tumors: is there a correlation between clinical status of patients and type of bone metastases? Clin Exp Metastasis. 2007;24(1):49–56. https://doi.org/10.1007/s10585-007-9056-z.
Asonitis N, Angelousi A, Zafeiris C, Lambrou GI, Dontas I, Kassi E. Diagnosis, pathophysiology and management of hypercalcemia in malignancy: a review of the literature. Horm Metab Res. 2019;51(12):770–8. https://doi.org/10.1055/a-1049-0647.
Article CAS PubMed Google Scholar
Grill V, Martin TJ. Hypercalcemia of malignancy. Rev Endocr Metab Disord. 2000;1(4):253–63. https://doi.org/10.1023/a:1026597816193.
Article CAS PubMed Google Scholar
Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005;352(4):373–9. https://doi.org/10.1056/NEJMcp042806.
Article CAS PubMed Google Scholar
Ramos REO, Perez Mak M, Alves MFS, Piotto GHM, Takahashi TK, da Gomes Fonseca L, et al. Malignancy-related hypercalcemia in advanced solid tumors: survival outcomes. J Glob Oncol. 2017;3(6):728–33. https://doi.org/10.1200/jgo.2016.006890.
Article PubMed PubMed Central Google Scholar
Legrand SB. Modern management of malignant hypercalcemia. Am J Hosp Palliat Care. 2011;28(7):515–7. https://doi.org/10.1177/1049909111414164.
Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med. 1990;112(7):499–504. https://doi.org/10.7326/0003-4819-112-7-499.
Article CAS PubMed Google Scholar
Cripe JC, Buchanan TR Jr, Wan L, Hagemann AR, McCourt CK, Massad LS, et al. Inpatient management of hypercalcemia portends a poor prognosis among gynecologic oncology patients: A trigger to initiate hospice care? Gynecol Oncol Rep. 2019;28:1–5. https://doi.org/10.1016/j.gore.2019.01.005.
Article PubMed PubMed Central Google Scholar
Bryson DJ, Wicks L, Ashford RU. The investigation and management of suspected malignant pathological fractures: a review for the general orthopaedic surgeon. Injury. 2015;46(10):1891–9. https://doi.org/10.1016/j.injury.2015.07.028.
Article CAS PubMed Google Scholar
Sernik JB, Yee AJM, Nousiainen MT. Pathological and Impending Fracture. In: Vassiliou V, Chow E, Kardamakis D, editors. Bone Metastases: A translational and Clinical Approach. Dordrecht: Springer, Netherlands; 2014. p. 323–40.
Van den Brande R, Cornips EM, Peeters M, Ost P, Billiet C, Van de Kelft E. Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review. J Bone Oncol. 2022;35:100446. https://doi.org/10.1016/j.jbo.2022.100446.
Comments (0)